November 2004 Maryse Lehners InitiativLiewensufank IBFAN1 Biomonitoring TWG Is continuing its work...

6
November 2004 Maryse Lehners Ini tiativLiewensufank IBFAN 1 Biomonitoring TWG Is continuing its work up to end of 2006 - Implementation Group (IG) for action 3 Reimbursements for travel costs and consultant Core group enlarged and ad hoc members Work program and mandate to be decided Table to select substance and matrix for pilot project Coordination with biomonitoring under REACH?

Transcript of November 2004 Maryse Lehners InitiativLiewensufank IBFAN1 Biomonitoring TWG Is continuing its work...

Page 1: November 2004 Maryse Lehners InitiativLiewensufank IBFAN1 Biomonitoring TWG  Is continuing its work up to end of 2006 - Implementation Group (IG) for.

November 2004 Maryse Lehners InitiativLiewensufank IBFAN

1

Biomonitoring TWG

Is continuing its work up to end of 2006 - Implementation Group (IG) for action 3

Reimbursements for travel costs and consultant

Core group enlarged and ad hoc members Work program and mandate to be decided Table to select substance and matrix for

pilot project Coordination with biomonitoring under

REACH?

Page 2: November 2004 Maryse Lehners InitiativLiewensufank IBFAN1 Biomonitoring TWG  Is continuing its work up to end of 2006 - Implementation Group (IG) for.

November 2004 Maryse Lehners InitiativLiewensufank IBFAN

2

Human biomonotoring Program of tomorrows session

Introduction (Action 3 of Action Plan)

Oral presentations (6) Posters (31) Discussion

Page 3: November 2004 Maryse Lehners InitiativLiewensufank IBFAN1 Biomonitoring TWG  Is continuing its work up to end of 2006 - Implementation Group (IG) for.

November 2004 Maryse Lehners InitiativLiewensufank IBFAN

3

8 questions to be addressed in presentations and discussion Contribution of your biomonitoring data to

policy measures relevant environ. health ? What was done with biomonitoring data

resulting from your project ? How were biomonitoring data integrated

with health monitoring data and environmental monitoring data ?

How were results communicated to study participants, decision makers, public, etc.?

Expertise, experiences, protocols etc. shared with other research/survey groups ?

What are the next steps ? Recommended objectives for an EU approach

for biomonitoring? What experiences should be taken into

consideration for a European Pilotproject?

Page 4: November 2004 Maryse Lehners InitiativLiewensufank IBFAN1 Biomonitoring TWG  Is continuing its work up to end of 2006 - Implementation Group (IG) for.

November 2004 Maryse Lehners InitiativLiewensufank IBFAN

4

Oral Presentations Biomonitoring

1. Germany: “German Environmental Survey (GerES)” by Kerstin Becker

2. Belgium: “Flemish biomonitoring: from pilot study (1999) to biomonitoring campaign (2002-2006) and follow-up” by Greet Schoeters

3. Portugal: “Biomonitoring activities in Portugal” by M. Fatima Reis

4. Poland: “Biological monitoring of environmental exposure to lead in children: an example of Poland” by Marek Jakubowski

5. Croatia: “Collaboration between cancer & miscarriage registers with biomonitoring databases in identifying populations at health risk as the basis for policymaking” by Alexandra Fucic

6. WHO: “Breast milk surveys” by R van Leeuwen.

Page 5: November 2004 Maryse Lehners InitiativLiewensufank IBFAN1 Biomonitoring TWG  Is continuing its work up to end of 2006 - Implementation Group (IG) for.

November 2004 Maryse Lehners InitiativLiewensufank IBFAN

5

Posters

Environmental exposure Biomarkers Mercury and cadmium Air quality WWF and IBFAN Reproductive health, children , adolescents

and environmental health well represented

Page 6: November 2004 Maryse Lehners InitiativLiewensufank IBFAN1 Biomonitoring TWG  Is continuing its work up to end of 2006 - Implementation Group (IG) for.

November 2004 Maryse Lehners InitiativLiewensufank IBFAN

6

Discussion

It is up to us to voice the right questions!